Roggenkamp D, Sammain A, Furstenau M, Kausch M, et al. Thiamidol((R)) in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase. J Dermatol 2021;48:1871-1876.
PMID: 34676600